financetom
Business
financetom
/
Business
/
Dick's Sporting Goods' Stock Weakness Puzzling Amid Strong Results, Raised Guidance, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dick's Sporting Goods' Stock Weakness Puzzling Amid Strong Results, Raised Guidance, Oppenheimer Says
Aug 29, 2025 6:14 AM

08:59 AM EDT, 08/29/2025 (MT Newswires) -- Dick's Sporting Goods' (DKS) recent share weakness doesn't align with its strong financial performance, Oppenheimer said in a note on Friday.

The brokerage firm said that despite a tough economic backdrop, the company posted better-than-expected Q2 results and raised its fiscal 2025 earnings forecast, citing strong sales across its portfolio.

DKS was also able to manage tariff pressures through supplier negotiations and selective price increases, with no hit to demand, Oppenheimer said.

Oppenheimer raised its fiscal 2025 earnings estimate to $14.45 per share from $14.40 and reaffirmed its fiscal 2026 view of $15.50, while maintaining its $270 price target.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MoneyLion Authorizes $20 Million Stock Buyback Program
MoneyLion Authorizes $20 Million Stock Buyback Program
Aug 26, 2024
08:37 AM EDT, 08/26/2024 (MT Newswires) -- MoneyLion ( ML ) said Monday that its board has approved the repurchase of up to $20 million of its outstanding class A shares. The repurchase program, which has no fixed expiration date, is expected to be funded from existing cash on hand and future cash flows, the company said. Shares of MoneyLion...
McKesson to buy controlling stake in Florida Cancer Specialists' unit for about $2.5 bln
McKesson to buy controlling stake in Florida Cancer Specialists' unit for about $2.5 bln
Aug 26, 2024
Aug 26 (Reuters) - Drug distributor McKesson said on Monday it would buy a controlling stake in community cancer center Florida Cancer Specialists & Research Institute's business and administrative services unit, Core Ventures, for $2.49 billion in cash. McKesson would acquire about a 70% stake in the unit, which would be part of its U.S. pharmaceutical segment. Upon the close...
China's PDD suffers $40 billion market cap wipeout after flagging an uncertain market
China's PDD suffers $40 billion market cap wipeout after flagging an uncertain market
Aug 26, 2024
(Reuters) -China's PDD Holdings missed market estimates for quarterly revenue on Monday, and downbeat comments from executives about China's domestic e-commerce competition and the firm's global outlook sent its shares down more than 28%. The biggest one-day share fall for PDD since it listed in the U.S. in 2018 wiped out nearly $40 billion in market capitalisation. The e-commerce retailer...
MIRA Pharmaceuticals Shares Surge Pre-Bell on 'Significant' Ketamir-2 Study Data
MIRA Pharmaceuticals Shares Surge Pre-Bell on 'Significant' Ketamir-2 Study Data
Aug 26, 2024
08:36 AM EDT, 08/26/2024 (MT Newswires) -- MIRA Pharmaceuticals ( MIRA ) shares surged nearly 46% in Monday's premarket activity after reporting that a pre-clinical study in rats showed that its ketamine analog, Ketamir-2, resulted in a 100% normalization of pain thresholds at the highest dose. This effect stands in stark contrast to traditional ketamine, which proved ineffective orally under...
Copyright 2023-2026 - www.financetom.com All Rights Reserved